Of the available 111 patients, 97 (87%) primary ccRCC tumors successfully stained for BAP1 (Table 1) and 20% showed loss of BAP1 expression (IHC negative). The gene discussed is BAP1; the disease is nonpapillary renal cell carcinoma.